Episodes

  • Episode 19: GLP-1 medicines - past, present, and future

    Episode 19: GLP-1 medicines - past, present, and future
    May 20 2025
    We talk with Prof. Daniel Drucker about the early work on GLP-1 medicines for the treatment of diabetes, how they are now impacting the lives of people living with obesity, and their potential use for many other indications.
    Show more Show less
    41 mins
  • Episode 18: The fight for children's eyesight

    Episode 18: The fight for children's eyesight
    Apr 15 2025
    Dr. Annegret Dahlmann-Noor explores why the number of children and adolescents with myopia is increasing and what we can do to halt the trend.
    Show more Show less
    30 mins
  • Episode 17: Challenges of developing DMOADs

    Episode 17: Challenges of developing DMOADs
    Mar 28 2025
    Prof. Ali Mobasheri identifies the key issues in developing a successful DMOAD and how they can be overcome.
    Show more Show less
    27 mins
  • Episode 16: Sexual health in older age

    Episode 16: Sexual health in older age
    Feb 27 2025
    Dr Holly Thomas helps us unpack the needlessly taboo subject of sex and sexual health in women of older age.
    Show more Show less
    30 mins
  • Episode 15: Breastfeeding after breast cancer

    Episode 15: Breastfeeding after breast cancer
    Jan 23 2025
    We talk to Dr. Cristina Saura about the concerns around breastfeeding after a breast cancer diagnosis, and why the POSITIVE results are such good news.
    Show more Show less
    18 mins
  • Episode 14: Diagnostic criteria for AD

    Episode 14: Diagnostic criteria for AD
    Dec 12 2024
    Dr. Nicolas Villain outlines why it is so important to consider both clinical symptoms and biological findings when diagnosing Alzheimer's disease.
    Show more Show less
    18 mins
  • Episode 13: Advances in MASLD and MASH

    Episode 13: Advances in MASLD and MASH
    Aug 14 2024
    Prof. Vlad Ratziu discusses the updated subclassification and nomenclature for steatotic liver disease, the therapeutic advance of resmetirom, and the future for MASLD and MASH.
    Show more Show less
    37 mins
  • Episode 12: Defining ARDS

    Episode 12: Defining ARDS
    Jul 5 2024
    Prof. Giacomo Grasselli takes us through the new concepts and explains why defining ARDS is such a difficult proposition.
    Show more Show less
    16 mins
adbl_web_global_use_to_activate_T1_webcro805_stickypopup